Actively Recruiting
Study of Bile-Derived Organoids From Patients With and Without Primary Sclerosing Cholangitis Aged 18 to 85
Led by Mayo Clinic · Updated on 2026-02-17
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Primary Sclerosing Cholangitis PSC, a liver condition, by collecting bile, bile duct brushings, and medical information from people with PSC and from controls without the disease. The goal is to better understand the biological changes in the liver associated with PSC by creating bile-derived organoids, which are small, simplified versions of bile duct cells grown in the lab. Participants diagnosed with PSC or controls without chronic liver disease will provide samples of bile andor bile duct brushings during medical procedures such as endoscopic retrograde cholangiopancreatography ERCP or gallbladder removal cholecystectomy. These samples will be grown using a specific method to create organoids for research. Both PSC patients and control participants will follow the same sample collection process. During the study, researchers will analyze the number of participants, the number and types of samples collected, and various clinical observations over a planned period of 20 years. Participants will be asked to provide samples during their medical procedures, and their clinical information will be collected to support the research. The study is observational and involves monitoring and data collection to learn more about PSC and related conditions.
CONDITIONS
Brief Title
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Research Team
E
Erik Schlicht, CCRP
J
Jackie Bianchi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here